FDA, MHRA, and Health Canada Signal a Growing Focus on Data Governance and Data Flows What Trial Sponsors Should Know About Clinical Study Data Flow Maps Under ICH E6(R3) At the start of June, during the 5th FDA-MHRA-Health Canada Symposium on Regulatory Perspectives in Good Clinical Practice, Bioequivalence & Good PV Practice, the FDA Lead for ICH E6(R3), described one […]
